Insight Molecular Diagnostics Inc. — Director's Dealing 2020

Dec 15, 2020

SEC Form 4/A — Form 4/A

Issuer: OncoCyte Corp (OCX)
CIK: 0001642380
Period of Report: 2018-08-30

Reporting Person: KINGSLEY ALFRED D (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	75345	Indirect
Common Stock	18767	Indirect

Footnotes

F1: This Form 4 is being filed to amend the prior Form 4 filed by the Reporting Person on September 4, 2018, which erroneously indicated that the shares of the Issuer's common stock are held directly by the Reporting Person.

F2: The shares of common stock are held by Greenbelt Corp. The Reporting Person is the President of Greenbelt Corp. and in such capacity has the right to vote and dispose of the securities held by such entity.

F3: This Form 4 is being filed to amend the prior Form 4 filed by the Reporting Person on September 4, 2018, which erroneously indicated that the shares of the Issuer's common stock are held directly by the Reporting Person.

F4: The shares of common stock are held by Greenway Partners, LP. The Reporting Person is the General Partner of Greenway Partners, LP and in such capacity has the right to vote and dispose of the securities held by such entity.